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In a recent study Helbig et al. [1] identify a recurrent variant in KCNA2, which encodes the voltage-
gated potassium channel, Kv1.2, as a novel cause of hereditary spastic paraplegia (HSP) in two 
unrelated families. Previously, gain-of-function and dominant-negative mutations in KCNA2 have 
been implicated in early-onset epileptic encephalopathies, ataxia or intellectual disability [2-4], 
making this an interesting and unexpected finding, where epilepsy and other neurodegenerative 
disorders overlap. 
We therefore, examined whole exome data and performed Sanger sequencing in a cohort of 
individuals with likely inherited neurological disorders and found one heterozygous de novo case 
with the same mutation described by Helbig et al. [1] (Figure 1). Their third family had a KCNA2 de 
novo mutation, however, had ataxia rather than spasticity at 20 years. 
The proband reported here presented as a teenager with progressive walking problems. There was 
no history of seizures or other neurological features. Clinical examination revealed dysarthria, 
spastic paraplegia and mild ataxia. The KCNA2 mutation we identified is a substitution of the first 
arginine residue in the voltage-sensing S4 segment of Kv1.2 with a histidine residue (c.881G>A, 
p.R294H). We performed site-directed mutagenesis on the complementary DNA of KCNA2, injected 
the RNA into Xenopus laevis oocytes and recorded currents using two-electrode voltage clamp. The 
current amplitude of the R294H mutant channel was reduced compared to wild type 
(Imax(Kv1.2)=5.7±0.6µA, n=15, Imax(R294H)=2.2±0.4µA, n=12, p<0.001, student’s t-test) and the 
voltage dependence of activation was right shifted (V1/2(Kv1.2)=-19.7±2.1mV, n=15, V1/2(R294H)=-
11.2±1.5mV, n=12, p<0.01, student’s t-test). Mutation R294H also exerted dominant negative effects 
when co-expressed with wild type (Figure 1). 
To conclude, we have identified a patient with HSP carrying a de novo R294H mutation in Kv1.2. Our 
results confirm that the R294H mutation is pathogenic, exerting a loss-of-function effect, consistent 
with published data [1]. The discovery of KCNA2 mutations in epilepsy, ataxia and HSP extends the 
phenotypes that can be associated with this gene but also highlights the clinical importance of the 
position of the mutated amino acid residue [5]. Further studies are required to better understand 
the molecular basis of this novel phenotype and how the specific mutation leads to spastic 
paraplegia. 
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Figure 1.A) Pedigree of the KCNA2 family. Open symbols represent unaffected individuals and filled 
symbols represent the affected individual. The proband is indicated by an arrow. Sanger sequencing 
chromatograms surround the symbols and show segregation of mutations. Black bars encompass 
the sites of interest. B) Structural conservation of the mutated amino acid residues in Kv1.2 across 6 
species (single letters = amino acid residues; black = identical; grey = conserved substitution; blue = 
loss-of-function mutations [2]; red = gain-of-function mutations [2]; purple = mutation found in this 
study); conservation among species of the affected amino acid residues was determined using 
Ensembl to retrieve the sequences and ClustalW2 software for multiple sequence alignment. C) 
Representative current traces of wild type and R294H Kv1.2 channels recorded in Xenopus laevis 
oocytes using two electrode voltage clamp. Test voltages ranged from -150 to +90 mV in 10 mV 
increments, tail voltage was -30 mV. Capacitive transients are not shown. The dashed lines show 
zero current level. The scale bars are 50 ms and 2 μA. D) The tail current amplitude is plotted against 
the test voltage for wild type (solid circles), n=15, R294H (solid squares), n=12, and heteromeric wild 
type/R294H channels (open triangles), n=16. Data shows the mean ± standard error of mean. The 
dashed lines show zero current level.  
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